Report Detail
Global Antidiabetic Drug Market Professional Survey Report 2019
- RnM3760108 |
- 18 September, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug
The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.
Based on the class of drug, the global anti-diabetic drug market is segmented into five types: sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. Sulphonylureas segment of oral anti-diabetic drugs market accounted for the largest market share in 2018followed by biguanides derivatives. Sulfonylureas were the largest segment and acquired around 37% of world market share followed by biguanide derivatives in 2018 Sulfonylureas are a class of organic compounds used in medicine and agriculture. They are antidiabetic drugs widely used in the management of type 2 diabetes mellitus. They act by increasing insulin release from the beta cells in the pancreas.
The global Antidiabetic Drug market was valued at 49600 million US$ in 2018 and will reach 96700 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2019-2025.
This report focuses on Antidiabetic Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antidiabetic Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antidiabetic Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antidiabetic Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Sanofi-Aventis
Eli Lilly
Oramed
Takeda
Boehringer Ingelheim
Novo Nordisk
Halozyme Therapeutics
Bristol-Myers Squibb
Pfizer
Tonghua Dongbao
Biocon
Wockhardt
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Alpha-Glucosidase Inhibitors
Biguanides, Sulphonylureas
Glp-1 Agonist
Meglitinides
Dpp-4 Inhibitors
Sglt–2
Thiazolodinediones
Segment by Application
Type I Diabetes
Type II Diabetes
Table of Contents
Executive Summary
1 Industry Overview of Antidiabetic Drug
- 1.1 Definition of Antidiabetic Drug
- 1.2 Antidiabetic Drug Segment by Type
- 1.2.1 Global Antidiabetic Drug Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Alpha-Glucosidase Inhibitors
- 1.2.3 Biguanides, Sulphonylureas
- 1.2.4 Glp-1 Agonist
- 1.2.5 Meglitinides
- 1.2.6 Dpp-4 Inhibitors
- 1.2.7 Sglt–2
- 1.2.8 Thiazolodinediones
- 1.3 Antidiabetic Drug Segment by Applications
- 1.3.1 Global Antidiabetic Drug Consumption Comparison by Applications (2014-2025)
- 1.3.2 Type I Diabetes
- 1.3.3 Type II Diabetes
- 1.4 Global Antidiabetic Drug Overall Market
- 1.4.1 Global Antidiabetic Drug Revenue (2014-2025)
- 1.4.2 Global Antidiabetic Drug Production (2014-2025)
- 1.4.3 North America Antidiabetic Drug Status and Prospect (2014-2025)
- 1.4.4 Europe Antidiabetic Drug Status and Prospect (2014-2025)
- 1.4.5 China Antidiabetic Drug Status and Prospect (2014-2025)
- 1.4.6 Japan Antidiabetic Drug Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Antidiabetic Drug Status and Prospect (2014-2025)
- 1.4.8 India Antidiabetic Drug Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Antidiabetic Drug
- 2.3 Manufacturing Process Analysis of Antidiabetic Drug
- 2.4 Industry Chain Structure of Antidiabetic Drug
3 Development and Manufacturing Plants Analysis of Antidiabetic Drug
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Antidiabetic Drug Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Antidiabetic Drug
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Antidiabetic Drug Production and Capacity Analysis
- 4.2 Antidiabetic Drug Revenue Analysis
- 4.3 Antidiabetic Drug Price Analysis
- 4.4 Market Concentration Degree
5 Antidiabetic Drug Regional Market Analysis
- 5.1 Antidiabetic Drug Production by Regions
- 5.1.1 Global Antidiabetic Drug Production by Regions
- 5.1.2 Global Antidiabetic Drug Revenue by Regions
- 5.2 Antidiabetic Drug Consumption by Regions
- 5.3 North America Antidiabetic Drug Market Analysis
- 5.3.1 North America Antidiabetic Drug Production
- 5.3.2 North America Antidiabetic Drug Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Antidiabetic Drug Import and Export
- 5.4 Europe Antidiabetic Drug Market Analysis
- 5.4.1 Europe Antidiabetic Drug Production
- 5.4.2 Europe Antidiabetic Drug Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Antidiabetic Drug Import and Export
- 5.5 China Antidiabetic Drug Market Analysis
- 5.5.1 China Antidiabetic Drug Production
- 5.5.2 China Antidiabetic Drug Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Antidiabetic Drug Import and Export
- 5.6 Japan Antidiabetic Drug Market Analysis
- 5.6.1 Japan Antidiabetic Drug Production
- 5.6.2 Japan Antidiabetic Drug Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Antidiabetic Drug Import and Export
- 5.7 Southeast Asia Antidiabetic Drug Market Analysis
- 5.7.1 Southeast Asia Antidiabetic Drug Production
- 5.7.2 Southeast Asia Antidiabetic Drug Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Antidiabetic Drug Import and Export
- 5.8 India Antidiabetic Drug Market Analysis
- 5.8.1 India Antidiabetic Drug Production
- 5.8.2 India Antidiabetic Drug Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Antidiabetic Drug Import and Export
6 Antidiabetic Drug Segment Market Analysis (by Type)
- 6.1 Global Antidiabetic Drug Production by Type
- 6.2 Global Antidiabetic Drug Revenue by Type
- 6.3 Antidiabetic Drug Price by Type
7 Antidiabetic Drug Segment Market Analysis (by Application)
- 7.1 Global Antidiabetic Drug Consumption by Application
- 7.2 Global Antidiabetic Drug Consumption Market Share by Application (2014-2019)
8 Antidiabetic Drug Major Manufacturers Analysis
- 8.1 Sanofi-Aventis
- 8.1.1 Sanofi-Aventis Antidiabetic Drug Production Sites and Area Served
- 8.1.2 Sanofi-Aventis Product Introduction, Application and Specification
- 8.1.3 Sanofi-Aventis Antidiabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Eli Lilly
- 8.2.1 Eli Lilly Antidiabetic Drug Production Sites and Area Served
- 8.2.2 Eli Lilly Product Introduction, Application and Specification
- 8.2.3 Eli Lilly Antidiabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Oramed
- 8.3.1 Oramed Antidiabetic Drug Production Sites and Area Served
- 8.3.2 Oramed Product Introduction, Application and Specification
- 8.3.3 Oramed Antidiabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Takeda
- 8.4.1 Takeda Antidiabetic Drug Production Sites and Area Served
- 8.4.2 Takeda Product Introduction, Application and Specification
- 8.4.3 Takeda Antidiabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Boehringer Ingelheim
- 8.5.1 Boehringer Ingelheim Antidiabetic Drug Production Sites and Area Served
- 8.5.2 Boehringer Ingelheim Product Introduction, Application and Specification
- 8.5.3 Boehringer Ingelheim Antidiabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Novo Nordisk
- 8.6.1 Novo Nordisk Antidiabetic Drug Production Sites and Area Served
- 8.6.2 Novo Nordisk Product Introduction, Application and Specification
- 8.6.3 Novo Nordisk Antidiabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Halozyme Therapeutics
- 8.7.1 Halozyme Therapeutics Antidiabetic Drug Production Sites and Area Served
- 8.7.2 Halozyme Therapeutics Product Introduction, Application and Specification
- 8.7.3 Halozyme Therapeutics Antidiabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Bristol-Myers Squibb
- 8.8.1 Bristol-Myers Squibb Antidiabetic Drug Production Sites and Area Served
- 8.8.2 Bristol-Myers Squibb Product Introduction, Application and Specification
- 8.8.3 Bristol-Myers Squibb Antidiabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Pfizer
- 8.9.1 Pfizer Antidiabetic Drug Production Sites and Area Served
- 8.9.2 Pfizer Product Introduction, Application and Specification
- 8.9.3 Pfizer Antidiabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Tonghua Dongbao
- 8.10.1 Tonghua Dongbao Antidiabetic Drug Production Sites and Area Served
- 8.10.2 Tonghua Dongbao Product Introduction, Application and Specification
- 8.10.3 Tonghua Dongbao Antidiabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Biocon
- 8.12 Wockhardt
9 Development Trend of Analysis of Antidiabetic Drug Market
- 9.1 Global Antidiabetic Drug Market Trend Analysis
- 9.1.1 Global Antidiabetic Drug Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Antidiabetic Drug Regional Market Trend
- 9.2.1 North America Antidiabetic Drug Forecast 2019-2025
- 9.2.2 Europe Antidiabetic Drug Forecast 2019-2025
- 9.2.3 China Antidiabetic Drug Forecast 2019-2025
- 9.2.4 Japan Antidiabetic Drug Forecast 2019-2025
- 9.2.5 Southeast Asia Antidiabetic Drug Forecast 2019-2025
- 9.2.6 India Antidiabetic Drug Forecast 2019-2025
- 9.3 Antidiabetic Drug Market Trend (Product Type)
- 9.4 Antidiabetic Drug Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Antidiabetic Drug Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Antidiabetic Drug . Industry analysis & Market Report on Antidiabetic Drug is a syndicated market report, published as Global Antidiabetic Drug Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Antidiabetic Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
